Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer

被引:75
|
作者
Liu, Yuanda [1 ]
Li, Changfeng [1 ]
Lu, Yaoping [2 ]
Liu, Chang [1 ]
Yang, Wei [2 ]
机构
[1] Jilin Univ, Dept Endoscopy Ctr, China Japan Union Hosp, Changchun, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
immune tolerance; tumor microenvironment; gastric cancer; immunotherapy; tumor-infiltrating immune cells; EPITHELIAL-MESENCHYMAL TRANSITION; NATURAL-KILLER-CELLS; T-CELLS; GASTROESOPHAGEAL JUNCTION; PATHOLOGICAL FUNCTIONS; M2; POLARIZATION; PROMOTES; MACROPHAGES; FIBROBLASTS; ACTIVATION;
D O I
10.3389/fimmu.2022.1016817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor microenvironment is the general term for all non-cancer components and their metabolites in tumor tissue. These components include the extracellular matrix, fibroblasts, immune cells, and endothelial cells. In the early stages of tumors, the tumor microenvironment has a tumor suppressor function. As the tumor progresses, tumor immune tolerance is induced under the action of various factors, such that the tumor suppressor microenvironment is continuously transformed into a tumor-promoting microenvironment, which promotes tumor immune escape. Eventually, tumor cells manifest the characteristics of malignant proliferation, invasion, metastasis, and drug resistance. In recent years, stress effects of the extracellular matrix, metabolic and phenotypic changes of innate immune cells (such as neutrophils, mast cells), and adaptive immune cells in the tumor microenvironment have been revealed to mediate the emerging mechanisms of immune tolerance, providing us with a large number of emerging therapeutic targets to relieve tumor immune tolerance. Gastric cancer is one of the most common digestive tract malignancies worldwide, whose mortality rate remains high. According to latest guidelines, the first-line chemotherapy of advanced gastric cancer is the traditional platinum and fluorouracil therapy, while immunotherapy for gastric cancer is extremely limited, including only Human epidermal growth factor receptor 2 (HER-2) and programmed death ligand 1 (PD-L1) targeted drugs, whose benefits are limited. Clinical experiments confirmed that cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), vascular endothelial growth factor receptor (VEGFR) and other targeted drugs alone or in combination with other drugs have limited efficacy in patients with advanced gastric cancer, far less than in lung cancer, colon cancer, and other tumors. The failure of immunotherapy is mainly related to the induction of immune tolerance in the tumor microenvironment of gastric cancer. Therefore, solving the immune tolerance of tumors is key to the success of gastric cancer immunotherapy. In this study, we summarize the latest mechanisms of various components of the tumor microenvironment in gastric cancer for inducing immune tolerance and promoting the formation of the malignant phenotype of gastric cancer, as well as the research progress of targeting the tumor microenvironment to overcome immune tolerance in the treatment of gastric cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer
    Yu, Jie
    Zhang, QianYun
    Wang, MengChuan
    Liang, SiJia
    Huang, HongYun
    Xie, Lang
    Cui, ChunHui
    Yu, JinLong
    BIOSCIENCE REPORTS, 2021, 41 (02)
  • [22] Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer
    Lee, Keunwook
    Hwang, Hyekyung
    Ki Taek Nam
    GUT AND LIVER, 2014, 8 (02) : 131 - 139
  • [23] The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer
    Koganemaru, Shigehiro
    Koyama, Shohei
    Suto, Fumitaka
    Koga, Makito
    Inaki, Koichiro
    Kuwahara, Yusuke
    Arita, Takeo
    Hirata, Tsuyoshi
    Goto, Hiroki
    Wada, Naoya
    Kobayashi, Maki
    Shibutani, Tomoko
    Okabayashi, Tatsuya
    Nakamaru, Kenji
    Kawazoe, Akihito
    Togashi, Yousuke
    Nishikawa, Hiroyoshi
    Shitara, Kohei
    CANCER RESEARCH COMMUNICATIONS, 2025, 5 (01): : 84 - 93
  • [24] Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer
    H. Kim
    Y. J. Heo
    Y. A. Cho
    S. Y. Kang
    S. Ahn
    K. -M. Kim
    Clinical and Translational Oncology, 2022, 24 : 556 - 567
  • [25] Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer
    Kim, H.
    Heo, Y. J.
    Cho, Y. A.
    Kang, S. Y.
    Ahn, S.
    Kim, K. M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (03): : 556 - 567
  • [26] Experimental study of glioma stem cell-mediated immune tolerance in tumor microenvironment
    谢涛
    China Medical Abstracts(Internal Medicine), 2018, 35 (01) : 61 - 62
  • [27] mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
    Mafi, Sahar
    Mansoori, Behzad
    Taeb, Shahram
    Sadeghi, Hossein
    Abbasi, Reza
    Cho, William C.
    Rostamzadeh, Davoud
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [28] Intestinal microenvironment-mediated allergic dynamic phenotypes and endotypes in the development of gluten allergy
    Xie, Qiang
    Liu, Chenglong
    Fu, Wenhui
    Chen, Chen
    Gu, Shimin
    Luo, Dan
    Xue, Wentong
    FOOD RESEARCH INTERNATIONAL, 2023, 169
  • [29] Tumor microenvironment-mediated immune profiles and efficacy of platinum doublet chemotherapy plus ICIs stratified by DLL3 expression in small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Shiraishi, Kouya
    Yagishita, Shigehiro
    Matsumoto, Yuji
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Naoki, Katsuhiko
    Tsuchida, Takaaki
    Hamamoto, Ryuji
    Yamamoto, Noboru
    Motoi, Noriko
    Kohno, Takashi
    Watanabe, Shun-ichi
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Dynamic changes of the immune microenvironment in the development of gastric cancer caused by inflammation
    Gan, Siyuan
    Li, Changfu
    Hou, Rui
    Tian, Geng
    Zhao, Yuan
    Ren, Dan
    Zhou, Wenjing
    Zhao, Fei
    Lv, Kebo
    Yang, Jialiang
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (03):